baber/WOPTO huggingface dataset:
Patent FI-915401-A0 (FI)
Inventor: BOEHM MICHAEL
IPC: D21H21/42
Filed: 1991-11-15
Abstract: The invention relates to a security document having an integral security element, preferably an optically variable element in the form of hologram, diffraction or interference structures applied to the paper surface, and to a process for making such a security document. The security document is characterised in that the optically variable element is embedded in the security document, the paper surface forming one plane with the surface of the optically variable element.
Patent FI-932082-A0 (FI)
Inventor: WOOD ERIC
IPC: F16L55/165
Filed: 1993-05-07
Abstract: An underground pipeline or passageway is lined by having a plastics film pre-liner tube applied thereto by inflation, and the tube whilst inflated has an applicator pulled therethrough from which a fluent curable or hardenable composition issues and is applied directly to the inside of the inflated tube to form a layer which cures or hardens to form a lining. Preferably a second tube is applied to the inside of the composition layer to hold it in position whilst it cures or hardens.
Patent FI-941180-A0 (FI)
Inventor: DIAS FRANCISCO J
IPC: C04B35/65
Filed: 1994-03-11
Abstract: PCT No. PCT/DE92/00753 Sec. 371 Date Mar. 11, 1994 Sec. 102(e) Date Mar. 11, 1994 PCT Filed Sep. 5, 1992 PCT Pub. No. WO93/06059 PCT Pub. Date Apr. 1, 1993.A process for producing a porous fluid permeable body which is heatable by the passage of electric current therethrough. The process involves coating silicon-containing particles with a cokable organic binder to produce coated particles with a particle size fraction of 0.2 to 10 mm, forming the particles into a molding, coking the binder and heating the molding at 1400 DEG  to 2000 DEG  C. in the presence of nitrogen to form a doped body containing 30% to 100%  beta -silicon carbide.
Patent FI-942820-A0 (FI)
Inventor: HEIKKINEN URHO
IPC: B66B11/08
Filed: 1994-06-14
Abstract: The invention relates to a suspension arrangement for a hydraulic elevator. Besides a normal diverting pulley (8) mounted on the top end of the piston (7), the arrangement comprises an additional diverting pulley (9) placed at the bottom end of the cylinder (5). The first end (10) of the elevator ropes (3) is fixed to a rope anchorage (11) in the car frame (4,15,19) of the elevator, from where the ropes are passed over the diverting pulley (8) on the top end of the piston to the additional diverting pulley (9), from which additional diverting pulley the ropes are further passed to an adapter (13) moving with the top end of the piston (7), the other end (12) of the ropes being attached to said adapter (13). <IMAGE>
Patent FI-950217-A0 (FI)
Inventor: WIEST WOLFGANG
IPC: B60K17/10
Filed: 1995-01-18
Abstract: PCT No. PCT/EP93/01593 Sec. 371 Date Nov. 29, 1994 Sec. 102(e) Date Nov. 29, 1994 PCT Filed Jun. 22, 1993 PCT Pub. No. WO94/02758 PCT Pub. Date Feb. 3, 1994.In a transmission unit (1) for arrangement between a drive motor (47) and a consuming device (48), including a hydrostatic transmission (2), adjustable by means of an adjusting device (15a, 15b), a mechanical shift transmission (4), functionally arranged downstream of the hydrostatic transmission, having a plurality of gears (5, 6), and a control device for adjusting the hydrostatic transmission (2) by means of the adjusting device (15a, 15b) for a shifting process. The shift transmission (4) is a synchronous transmission with synchronization devices (7) for the gears (5, 6), including a device (U, V2) for the measuring or monitoring of the output drive torque (M) of the hydrostatic transmission (2) is associated with the control device (16). In the event that before a process of gear shifting the output drive torque (M) is greater than the working moment of the associated synchronization device (7, 7a) the control device (16) sets an output drive torque (M) at the hydrostatic transmission (2) through the adjustment device (15a, 15b), which is equal to or smaller than the working moment of the synchronization device which is associated with the relevant gear (6, 7).
Patent FI-954644-A0 (FI)
Inventor: CLARK PAUL EATON
IPC: H02K3/34
Filed: 1995-09-29
Abstract: In a large rotating electrical machine having a rotor comprising conductor bars of copper located in slots in a rotor core and connected together at their ends to form a winding, the conductor bars are electrically insulated from the rotor core by a coating on the conductors of a ceramic-based material. The coating serves to prevent sparking occurring between the conductor bars and the rotor core.
Patent FI-973193-A0 (FI)
Inventor: NIELSEN TORBEN HOLST
IPC: E06B9/264
Filed: 1997-08-01
Abstract: A dual window screening device comprises a first screening element (1) with a breadth of flexible screening material, which in the end is rolled  up on a roller tube (2) at one of a pair of sash members positioned opposite each other (4), whereas the opposite end is connected with an end rail profile (5). A second screening element (8) is in one end fastened to the opposite sash member (9) and in the opposite end connected with an end rail profile (10). The screening device may be designed for manual or electronic operation and comprises guiding and arresting means permitting mutually independent adjustment of the two screening elements (1, 8) in arbitrary positions. The guiding and arresting means comprise a common guide track (11) for the screening elements so that these are used in a common guiding plane.
Patent IL-64942-A0 (IL)
Title: Molten metal sampling device
IPC: G01N1/12
Filed: 1982-02-05
Abstract: In a molten metal sampling device having a porous filter connected by a conduit to a reservoir in such a manner that molten metal can be drawn, by vacuum, down into the filter and then to the reservoir, a removable seat for the filter, a stopper rod to prevent the flow of metal until the optimum moment, and an insulated, inert lining for the unsubmerged parts, which is permeable to generated gases, are provided.
Patent IL-79920-A0 (IL)
Title: 3-amino-dihydro-(1)-benzopyrans and benzothiopyrans and pharmaceutical compositions containing them
IPC: A61K31/352
Filed: 1986-09-02
Abstract: Compounds of the formula: <IMAGE> in which Z denotes oxygen or sulphur, R denotes hydrogen or lower alkyl, R1 denotes hydrogen, lower alkyl or aryl(lower alkyl), R2 denotes hydrogen, lower alkyl or aryl(lower alkyl) or R1 and R2 together denote alkylene having 4-6 C atoms, R3 denotes hydrogen, hydroxyl, lower alkoxy, aryl(lower alkoxy), acyloxy or aryloxy in compounds having the meaning sulphur for Z, R3 denotes hydroxyl, lower alkoxy, aryl(lower alkoxy), acyloxy or aryloxy in compounds having the meaning oxygen for Z and R3 is bonded in position 5 or 8 in compounds having the meaning oxygen for Z, and R4 and R5 independently of one another denote hydrogen, lower alkyl or halogen, and pharmaceutically acceptable salts thereof, or mono- or di-S-oxides of compounds of the formula I in which Z denotes sulphur.   The compounds can be used as modulators for the receptors of the central nervous system, for example as serotonin receptor antagonists in the treatment of disorders of the central nervous system.
Patent IL-79928-A0 (IL)
Title: Spiro(benzofuran-2(3h),1'-cycloheptane)s,a process and intermediates for their preparation and their use as medicaments
IPC: A61P25/24
Filed: 1986-09-02
Abstract: There are described compounds of the formulawhere each X is independently H, halogen, loweralkyl, loweralkoxy or OH; m is 1 or 2; and R is -H, =0,=CH(CH<sub>2</sub>)<sub>n</sub>NR<sub>1</sub>CH<sub>3</sub>, -CH<sub>2</sub>(CH<sub>2</sub>)<sub>n</sub>NR<sub>1</sub>R<sub>2</sub>, =N-OH, =N-OCH<sub>2</sub>(CH<sub>2</sub>)<sub>n</sub>NR<sub>1</sub>R<sub>3</sub>,=N-OCH<sub>2</sub>CHOHCH<sub>2</sub>NR<sub>1</sub>R<sub>3</sub>, -NR<sub>2</sub>R<sub>3</sub>, -OH or -OCH<sub>2</sub>(CH<sub>2</sub>)<sub>n</sub>NR<sub>1</sub>R<sub>2</sub>, n being 1 or 2, R, being loweralkyl, R<sub>2</sub> being H, loweralkyl, loweralkanoyl, arylloweralkyl, arylloweralkanoyl, diarylloweralkyl, diarylloweralkanoyl, -CO<sub>2</sub>C<sub>2</sub>H<sub>5</sub> or -CN, and R<sub>3</sub> being H, loweralkyl, arylloweralkyl or diarylloweralkyl, or a pharmaceutically acceptable acid addition salt thereof, which are useful as antihypertensive, anticonvulsant, analgesic and antidepressant agents.
Patent IL-92055-A0 (IL)
Title: Process and intermediates for preparing imidazoquinoxalines
IPC: A61K31/495
Filed: 1989-10-19
Abstract: A novel chemical process for preparing imidazoquinoxalines bearing hydrogen substitution in the 5-position comprises dealkylation of the novel corresponding 5-tert-butyl compound (which also has vaulable pharmacological properties).
Patent FI-20002104-A0 (FI)
Inventor: SALMISUO MAURI
IPC: B01D1/22
Filed: 2000-09-25
Abstract: An evaporation product discharged from a lower end a falling-film evaporator enters a downpipe (7), makes a 180° turn at a bottom of the downpipe, and moves upward through an annular rising channel (9) defined between the downpipe and an intermediate housing (10). As the evaporation product moves along a spiral path (12) defined by the spiral fins, centrifugal forces urges water droplets and impurities to a radial outward periphery where they pass through openings (13) in the intermediate shell as pure steam continues through the spiral path and out a pure steam outlet (21). A cooling jacket (15) chills a peripheral wall of an outer shell (14) adjacent the holes such that the discharged water droplets condense on the outer shell and flow down a reject water return path to a reject water reservoir at the bottom of the outer shell.
Patent FI-20002699-A0 (FI)
Inventor: FUGLEBERG SIGMUND
IPC: C25C1/16
Filed: 2000-12-08
Abstract: The invention relates to a method for the hydrolytic precipitation of iron as jarosite from a sulphate-containing solution in connection with zinc recovery from zinc calcine. The recovey contains neutral leach, ferrite leach, zinc electrolysis and iron precipitation stages. The ferrite included in the calcine is leached with return acid of the electrolysis after which the iron present in ferrous form is neutralized and routed to an iron precipitation stage, where the iron is oxidised to the trivalent form using an oxygen-containing gas. Also present in the precipitation stage arc Na, K or NH<SUB>4 </SUB>ions and jarosite nuclei.
Patent FI-20085298-A0 (FI)
Inventor: HENRIKSSON TORBJOERN
IPC: F01N13/08
Filed: 2008-04-09
Abstract: The invention relates to a machinery arrangement, which comprises a combus-tion unit (3) arranged in an engine room (11), and an exhaust gas duct assem-bly (4) connected to the combustion unit (3) for receiving an exhaust gas flow and for leading the exhaust gas flow to the atmosphere through an exhaust gas cleaning system (5) provided with an exhaust gas pipe (52). In order to condi-tion the exhaust plume, the exhaust gas pipe (52) is arranged in an enclosure (114), whereby the enclosure (114) is arranged in flow connection with the en-gine room (11) in order to provide heat for the exhaust gas pipe (52) by means of a heated air flow from the engine room.
Patent FI-20085374-A0 (FI)
Inventor: ROESGREN CARL-ERIK
Filed: 2008-04-25
Abstract: A pre-chamber unit (1) of the cylinder of a combustion engine, comprising a pre- chamber (2) and an elongated nozzle chamber (3) connected thereto, a number of orifices (4) being provided at its oneend for connecting the pre-chamber to the main combustion space(5) of the cylinder. The nozzle chamber (3) comprises a part (3b) that is enlarged at least at the position of the orifices (4), its diameter in the transversal direction of the nozzle chamber (3) being larger than that of the part (3a) between the orifices and the pre-chamber.
Patent FI-20115318-A0 (FI)
Inventor: YLI-KOSKI ESKO
IPC: F16L/
Filed: 2011-04-04
Abstract: Disclosed is a device for reducing flow noise. In order to achieve a low flow noise, the device includes inlet apertures for receiving a fluid flow, chambers into which one or more inlet apertures open up, a cross-sectional area of a single chamber being larger than a combined flow cross-sectional area of the inlet apertures opening up thereto, and chamber-specific outlet apertures for forwarding the fluid flow from the chamber, a flow cross-sectional area of each outlet aperture being smaller than the cross-sectional area of the chamber, and the combined flow cross-sectional area of all outlet apertures of the single chamber being larger than the combined flow cross-sectional area of the inlet apertures opening up into said chamber.
Patent IL-105421-A0 (IL)
Title: Taxol derivatives
IPC: A61K31/337
Filed: 1993-04-16
Abstract: Compounds having the formula   <IMAGE>   wherein -OR1 comprises the C-13 side-chain of taxol and R3 comprises hydrogen, as well as a method for the preparation thereof.
Patent IL-107837-A0 (IL)
Title: Spiro piperidines and homologs, their preparation and pharmaceutical compositions containing them
IPC: A61K38/04
Filed: 1993-12-02
Abstract: There are disclosed certain novel compounds identified as spiro piperidines and homologs which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such spiro compounds as the active ingredient thereof are also disclosed.
Patent IL-109635-A0 (IL)
Title: Substituted arylcycloalkyl derivatives and pharmaceutical compositions containing them
IPC: A61P25/00
Filed: 1994-05-12
Abstract: PCT No. PCT/EP94/01494 Sec. 371 Date Dec. 22, 1995 Sec. 102(e) Date Dec. 22, 1995 PCT Filed May 7, 1994 PCT Pub. No. WO94/26704 PCT Pub. Date Nov. 24, 1994Compounds of formula I    <IMAGE>  I  and pharmaceutically acceptable salts thereof in which m is 0, 1 or 2; n is 2, 3, 4 or 5; X is carbonyl or a group of formula II    <IMAGE>  II  in which R5 is H or alkyl; Y is an alkylene chain optionally substituted by one or more alkyl groups; Z is an alkylene chain containing 2 to 5 carbon atoms optionally substituted by one or more alkyl groups; R is phenyl optionally substituted by one or more halo substituents or R is naphthyl; and R1 and R2, which are the same or different, are H, alkyl, or arylalkyl, provided that when R1 is benzyl, R2 is H or methyl; have utility in the treatment of depression, anxiety, Parkinson's disease, obesity, cognitive disorders, seizures, neurological disorders such as epilepsy, and as neuroprotective agents to protect against conditions such as stroke.
Patent IL-110872-A0 (IL)
Title: Organization of optical fibres
IPC: G02B6/38
Filed: 1994-09-05
Abstract: PCT No. PCT/GB94/01913 Sec. 371 Date Mar. 6, 1996 Sec. 102(e) Date Mar. 6, 1996 PCT Filed Sep. 2, 1994 PCT Pub. No. WO95/07480 PCT Pub. Date Mar. 16, 1995A base for an optical fibre organizer, which comprises: a first passage along one longitudinal edge portion for incoming fibres; a second pasage along an opposite longitudinal edge portion for outgoing fibres; a plurality of first fibre guides separated from one another along the length of the base and extending from the first passage across the base towards the second passage where fibre in said guides are directed away from the plane of the base; a plurality of second fibre guides separated from one another along the length of the base and extending from the second passage across the base towards the first passage where fibres in said guides are directed away from the plane of the base.
Patent IL-111285-A0 (IL)
Title: Methods of inhibiting uterine fibrosis
IPC: A61K31/381
Filed: 1994-10-13
Abstract: A method of inhibiting uterine fibrosis comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula <CHEM>   Wherein R<1> and R<3> are independently hydrogen, -CH3, <CHEM>  or <CHEM>  wherein Ar is optionally substituted phenyl; wherein R<2> is selected from the group consisting of pyrrolidino and piperidino, a pharmaceutically acceptable salt or solvate thereof.
Patent IL-147722-A0 (IL)
Title: Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
IPC: A61K35/12
Filed: 2000-07-20
Abstract: The present invention provides a molecular marker for the identification of pluripotent pre-mesenchymal, pre-hematopoietic stem cells. The invention further provides primitive progenitor cells identified by the molecular marker. Such cells have the potential to differentiate into both mesenchymal and hematopoietic phenotypes, as determined by a proliferative response to inductive growth factors and cytokines, and by their morphologic and cytochemical features.
Patent IL-148535-A0 (IL)
Title: Metal cutting tool
IPC: B23B27/08
Filed: 2002-03-06
Abstract: The insert has a peripheral side surface (42) extending between two opposing end surfaces (40) with 180 degree rotational symmetry about an axis (R1) and includes two opposing major and minor side surfaces (46,44) having 180-degree rotational symmetry about respective axes (R2, R3). The end surface has four corners that are equidistant from major and minor planes.
Patent IL-157833-A0 (IL)
Title: Use of heat in cold storage appliances
IPC: B65D88/12
Filed: 2002-03-13
Abstract: A cold-storage appliance includes an open-topped insulating container defining an external surface; an insulating lid adapted to close the open top of the container; a cooling means adapted to cool the interior of the container; and a structure supporting the container, the lid and the cooling means; wherein the container is mounted to the structure for movement relative to the structure and the lid to open the container and afford access to its interior or to close the container.
Patent IL-176635-A0 (IL)
Title: Antibody purification
IPC: C07K16/00
Filed: 2006-06-29
Abstract: The present invention relates to a method of separating antibodies from contaminants in a solution, which method comprises contacting the solution with a chromatography resin comprised of a support to which multi-modal ligands have been immobilised, wherein a multi-modal ligand comprises at least one cation-exchanging group and at least one aromatic or heteroaromatic ring system. In one embodiment, the ring-forming atoms of the aromatic or hereoaromatic entity are selected among C, S or O, and the cation exchanging group is a weak cation exchanger. The present method may be used as a single step procedure or as a polishing step following a capture on a Protein A column.
Patent IL-179103-A0 (IL)
Title: Techniques for nerve stimulation
Filed: 2006-11-07
Abstract: Apparatus for applying current to a nerve (30), comprises an electrode assembly (20), which comprises: a housing (22), adapted to be placed around the nerve (30); and two or more cathodes (141a, 141b), fixed to the housing (22) at respective different cathodic longitudinal locations, and one or more anodes (142), fixed to the housing (22) at respective anodal longitudinal locations; a control unit (140), which is coupled to the cathodes (141a, 141b) and the anodes (142), and which is configured to drive the cathodes (141a, 141b) to apply respective cathodic currents to the nerve (30), and the anodes (142) to apply respective anodal currents to the nerve (30), characterized in that (a) no anodes (142) are positioned longitudinally between the two or more cathodes (141a, 141b), and (b) no cathodes (141a, 141b) are positioned longitudinally between the one or more anodes (142).
Patent IL-183218-A0 (IL)
Title: Oily mixture of natural bioactive ingredients for the preparation of an enriched food product
IPC: A23L13/40
Filed: 2007-05-15
Abstract: The present invention provides an oily mixture based on natural bioactive ingredients to be used to prepare an enriched food product that includes salmon oil enriched with EPA and DHA, alpha-tocopherol and supercritical rosemary extract. Optionally, this mixture can contain the microalga  Dunaliella salina.  The invention also provides a food product enriched with this oily mixture based on natural bioactive ingredients. This enriched food product has great benefits for human health owing to its stable contents of polyunsaturated fatty acids with a É-3 to É-6 ratio lower than 5, of alpha-tocopherol, phenolic diterpenes derived from supercritical rosemary extract and, optionally, carotenoids derived from the microalga  Dunaliella salina.  Finally, the invention also refers to a method to prepare this enriched food product.
Patent IL-190542-A0 (IL)
Title: Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
IPC: C12N1/15
Filed: 2008-03-31
Abstract: Amino acid sequences (I) that facilitate penetration of a substance of interest (II) into the inside of a cell and/or its nucleus. (I) can react in vivo with aminoglycans (AG) or can react with AG (sic) and are derived from proteins of human origin. Independent claims are also included for the following: (1) associations of (I) and (II); (2) intracytoplasmic and/or intranuclear transfer vectors consisting of, or containing, at least one (I); (3) eukaryotic cells that contain (I) or the vector of (2) or are transfected with this vector; (4) process for in vitro transfer of (II) into cells; (5) composition (biological, pharmaceutical, cosmetic, nutritional, diagnostic or tracer) containing as active agent a vector of (2) or a cell of (3); (6) diagnostic agent comprising the vector of (2) or the cells of (3); and (7) diagnostic kit containing, in one or more vessels, a predetermined quantity of the composition of (5). ACTIVITY : Antiviral; antibacterial; cytostatic; anti-apoptotic; vasotropic; hemostatic. No supporting data given. MECHANISM OF ACTION : Gene or protein replacement; gene therapy. No supporting data given.
Patent IL-205297-A0 (IL)
Title: Networks having multiple paths between nodes and nodes for such a network
Filed: 2010-04-22
Abstract: A network (1) comprising a plurality of nodes (2, 3, 4), the plurality of nodes comprising a first node (A) and a second node (B), the first (A) and second (B) nodes being connected through the network of nodes (1) via a first path (2) and a second path (3), the first and second paths being different, in which the network (1) has first and second modes of operation, a first mode (108) in which traffic between the first and second nodes is transmitted over the first path (2) and not the second path (3), and a second mode (106) where the traffic is transmitted over the first (2) and second (3) paths, wherein the network (1) comprises a mode selector (10) arranged to select the mode of operation based upon a demanded level of traffic between the first (A) and second (B) nodes.
Patent IL-216046-A0 (IL)
Title: Fused compounds containing an ureido group that inhibit vanilloid receptor subtype 1 (vr1) receptor ,for treating disorders caused by vanilloid receptor activity and process for their preparation
IPC: C07D401/12
Filed: 2011-10-30
Abstract: The present invention discloses novel compounds of general formula (I), or a pharmaceutically acceptable salt thereof (in which X 1  - X 5 , R 5  - R 8b , Z 1  - Z 2  and Ar 1  are defined herein), pharmaceutical compositions including those compounds and a process for making those compounds. The compounds of formula (I) are useful for treating pain, bladder overreactivity, urinary incontinence, inflammatory hyperalgesia by inhibiting the VR1 receptor in mammals.